Altered hippocampal muscarinic M4, but not M1, receptor expression from subjects with schizophrenia
- PMID: 17239354
- DOI: 10.1016/j.biopsych.2006.08.050
Altered hippocampal muscarinic M4, but not M1, receptor expression from subjects with schizophrenia
Abstract
Background: Having shown a decrease in [3H]pirenzepine binding in the hippocampus from subjects with schizophrenia, we wished to determine whether such a change in radioligand binding was associated with changes in hippocampal mRNA for the muscarinic1 (M1) and muscarinic4 (M4) receptors in tissue from different cohorts of subjects.
Method: The [3H]pirenzepine binding using autoradiography and in situ hybridization with oligonucleotides specific for muscarinic M1 and M4 receptors were completed using hippocampal tissue obtained postmortem from 20 control subjects and 20 subjects with schizophrenia.
Results: The [3H]pirenzepine binding was decreased in the dentate gyrus (p < .05), CA3 (p < .01), CA2 (p < .05), and CA1 (p < .01) regions of the hippocampus from subjects with schizophrenia. Levels of M4 mRNA varied with the diagnosis of schizophrenia (p = .01), but significant region-specific changes were not apparent. Changes in levels of mRNA for the muscarinic M1 receptor were not detected with diagnosis.
Conclusions: This study suggests that decreases in hippocampal [3H]pirenzepine binding in subjects with schizophrenia are most likely associated with widespread changes in expression levels of the M4 receptor. These data further implicate the hippocampal formation in the pathology of schizophrenia.
Similar articles
-
Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia.Mol Psychiatry. 2002;7(10):1083-91. doi: 10.1038/sj.mp.4001199. Mol Psychiatry. 2002. PMID: 12476323
-
5-HT2A and muscarinic receptors in schizophrenia: a postmortem study.Neurosci Lett. 2005 May 13;379(3):164-8. doi: 10.1016/j.neulet.2004.12.059. Epub 2005 Jan 25. Neurosci Lett. 2005. PMID: 15843056
-
Decreased density of muscarinic receptors in the superior temporal gyrusin schizophrenia.J Neurosci Res. 2005 Sep 15;81(6):883-90. doi: 10.1002/jnr.20600. J Neurosci Res. 2005. PMID: 16041805
-
Muscarinic M1 and M4 receptor agonists for schizophrenia: promising candidates for the therapeutic arsenal.Expert Opin Investig Drugs. 2023 Jul-Dec;32(12):1113-1121. doi: 10.1080/13543784.2023.2288074. Epub 2023 Dec 28. Expert Opin Investig Drugs. 2023. PMID: 37994870 Review.
-
Muscarinic M1 and M4 receptors: Hypothesis driven drug development for schizophrenia.Psychiatry Res. 2020 Jun;288:112989. doi: 10.1016/j.psychres.2020.112989. Epub 2020 Apr 13. Psychiatry Res. 2020. PMID: 32315882 Review.
Cited by
-
Prefrontal gray matter morphology mediates the association between serum anticholinergicity and cognitive functioning in early course schizophrenia.Psychiatry Res. 2012 Nov 30;204(2-3):61-7. doi: 10.1016/j.pscychresns.2012.04.014. Epub 2012 Nov 15. Psychiatry Res. 2012. PMID: 23158779 Free PMC article. Clinical Trial.
-
Muscarinic receptors: their roles in disorders of the central nervous system and potential as therapeutic targets.CNS Neurosci Ther. 2012 May;18(5):369-79. doi: 10.1111/j.1755-5949.2011.00249.x. Epub 2011 Feb 26. CNS Neurosci Ther. 2012. PMID: 22070219 Free PMC article. Review.
-
Regulation of Glutamatergic Activity via Bidirectional Activation of Two Select Receptors as a Novel Approach in Antipsychotic Drug Discovery.Int J Mol Sci. 2020 Nov 20;21(22):8811. doi: 10.3390/ijms21228811. Int J Mol Sci. 2020. PMID: 33233865 Free PMC article. Review.
-
The Role of G Protein-Coupled Receptors (GPCRs) and Calcium Signaling in Schizophrenia. Focus on GPCRs Activated by Neurotransmitters and Chemokines.Cells. 2021 May 17;10(5):1228. doi: 10.3390/cells10051228. Cells. 2021. PMID: 34067760 Free PMC article. Review.
-
Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis.Front Cell Neurosci. 2013 Jun 26;7:95. doi: 10.3389/fncel.2013.00095. eCollection 2013. Front Cell Neurosci. 2013. PMID: 23805071 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous